Today: 7 February 2026
Subscribe

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Slashes Wegovy and Ozempic Cash Prices to $349, Launches $199 Intro Deals as GLP‑1 Price War Escalates

Published November 17, 2025 Novo Nordisk moved aggressively today to cut out‑of‑pocket costs for its blockbuster GLP‑1 drugs Wegovy and Ozempic, unveiling new self‑pay prices and limited‑time offers that it says will reach tens of thousands of U.S. pharmacies and telehealth partners. The changes come just days after the Trump administration struck landmark pricing agreements with Novo Nordisk and Eli Lilly that will extend Medicare and Medicaid coverage to obesity drugs for the first time and launch a government-run discount pharmacy site, TrumpRx, in early 2026. The White House+2Reuters+2 At the same time, telehealth and discount platforms including GoodRx and
17 November 2025
·
Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (NYSE: CRM) shares spent Monday under pressure, trading around the high‑$230s to low‑$240s and finishing the session near $239 per share, roughly 1.5–1.8% lower on the day, according to intraday and historical data.Investing.com The AI‑driven CRM leader is still sitting well below its 52‑week high in the mid‑$360s, despite steadily growing revenue and earnings. At the same time, Wall Street remains broadly bullish. Bank of America and Mizuho both trimmed their price targets today but kept positive ratings, while the consensus one‑year target across major brokerages still sits in the low‑$320s — implying roughly 35–38% upside from current levels.MarketBeat+2GuruFocus+2
17 November 2025
·
Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (NASDAQ: KXIN) is back in the spotlight on Monday, with its stock more than doubling in volatile trade and landing among the most active names on the Nasdaq, even as the broader U.S. market trades lower. Benzinga+2Yahoo Finance+2 By late morning U.S. time on 17 November 2025, KXIN was changing hands around $0.65, up well over 100% from Friday’s close near $0.31. Different real‑time feeds show an intraday range of roughly $0.38–$0.75 and more than 180–200 million shares traded — enormous turnover for a stock whose average daily volume has recently been under 1 million shares. Investing.com+1 KXIN
17 November 2025
·
LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (NASDAQ: LFMD) announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss market LifeMD Announces $199 Cash-Pay Pricing for Wegovy and Ozempic This morning, LifeMD, Inc. (NASDAQ: LFMD) unveiled what it calls the lowest cash‑pay pricing available nationwide for the GLP‑1 weight‑loss drugs Wegovy and Ozempic, in continued collaboration with Novo Nordisk. MarketScreener+3GlobeNewswire+3Quiver Quantitative+3 Under the new offer: The move builds on LifeMD’s shift away from compounded GLP‑1s toward direct partnerships with
17 November 2025
Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

On Monday, 17 November 2025, shares of The Vita Coco Company, Inc. (NASDAQ: COCO) surged to fresh record levels after the White House moved to exempt coconut water from new reciprocal tariffs and Bank of America (BofA) upgraded the stock to Buy with higher 2026 profit estimates.Nasdaq+2Investing.com+2 The rally caps several weeks of strong news flow for the coconut‑water leader, including robust third‑quarter results, raised full‑year guidance, and ongoing share repurchases.TradingView+2Simply Wall St+2 Key takeaways for today (17 November 2025) COCO stock price today: rally extends to record territory As of late trading on 17 November, COCO is changing hands
17 November 2025
HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

Hewlett Packard Enterprise (NYSE: HPE) is in the spotlight today as Wall Street reacts to a fresh analyst downgrade, a major divestment in China, and ongoing bets on AI, hybrid cloud and supercomputing. HPE shares under pressure after Morgan Stanley downgrade Hewlett Packard Enterprise started the week on the defensive as Morgan Stanley downgraded the stock to “Equal-weight” from “Overweight” and cut its price target to $25 from $28. The bank flagged what it called an “unprecedented” memory pricing cycle, with DRAM and NAND prices up roughly 50% to as much as 300% over the last six months, squeezing margins
17 November 2025
Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (NYSE: ARMK) reported its fiscal fourth‑quarter and full‑year 2025 results before the U.S. market opened on Monday, November 17, 2025. The numbers showed strong full‑year growth, record new business wins and a higher dividend — but a softer‑than‑expected Q4 and “lofty” expectations sent the stock lower in today’s session. Business Wire+2Investing.com Canada+2 By late afternoon, Aramark shares were trading around $35.98, down roughly 5–6% from Friday’s close, on heavy volume. The drop follows a pre‑market slide that earlier reached nearly 8% after investors digested the earnings miss and guidance. Investing.com Canada+1 At the same time, management laid out a
17 November 2025
·
PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

Clean‑energy developer and IPP PowerBank Corporation (NASDAQ: SUUN, Cboe CA: SUNN) swings back to profit as it leans into solar, storage and AI‑driven project planning. PowerBank Corporation, the Canadian‑based solar and battery storage developer formerly known as SolarBank, reported a profitable first quarter of fiscal 2026 today and unveiled a fresh milestone in its AI partnership with Intellistake Technologies, sending the thinly traded renewable‑energy stock back into the spotlight. Powerbank Corporation+1 Q1 2026: PowerBank posts first quarterly profit since major write‑downs In a designated earnings release covering the three months ended 30 September 2025, PowerBank said it: Powerbank Corporation+1 Earnings
17 November 2025
···
Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle stock (NYSE: ALB) jumped around 8–9% on November 17, 2025, as lithium prices hit a one‑year high and Argus raised its price target to $140. Here’s what’s driving the move, how Wall Street is reacting, and what it could mean for investors. Albemarle stock is on fire today Albemarle stock has been in rally mode for days, but today’s move stands out even in a strong November run. German market outlet wallstreet‑online describes today’s advance as a “kräftiger Gewinn” (strong gain), pointing out that: wallstreet-online.de In other words, today is not a random pop – it’s part of a
17 November 2025
Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

As of mid-afternoon on November 17, 2025, Canadian Solar Inc. (CSIQ) is trading around $29–30 per share, after an extremely volatile few sessions that saw the stock spike to the mid‑$30s following its Q3 2025 earnings release. MarketBeat 1. Stock performance: from laggard to November high‑flyer Canadian Solar has turned into one of November’s surprise momentum stories: Today’s action looks more like consolidation after a huge run: the real story on November 17 is in the newsflow around battery storage, analyst calls and insider activity, rather than another big price spike. 2. Q3 2025 earnings: revenue and margin beat, but
17 November 2025
··
Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

On Monday, November 17, 2025, Clearwater Analytics Holdings, Inc. (NYSE: CWAN) once again jumped onto traders’ radar as renewed buyout speculation from private equity giants Warburg Pincus and Permira pushed the stock sharply higher in pre‑market trading and kept it among the day’s notable movers. TradingView+2Benzinga+2 Below is a full rundown of what’s driving Clearwater Analytics today, how it fits into the company’s broader AI and growth story, and what investors are watching next. CWAN Stock Today: Double‑Digit Premarket Spike, Still Volatile Mid‑Session Clearwater Analytics shares extended last week’s rally in Monday’s pre‑market session: By late morning, the move had
17 November 2025
·
E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

On November 17, 2025, Sinclair Inc. disclosed an 8.2% stake in The E.W. Scripps Company (NASDAQ: SSP) and confirmed it is pursuing a merger, sending SSP stock more than 20% higher. Here’s what the potential Sinclair–Scripps deal means for investors, the local TV landscape and sports rights. The E.W. Scripps Company (NASDAQ: SSP) is at the center of one of the biggest media storylines of 2025 after rival broadcaster Sinclair Inc. (NASDAQ: SBGI) revealed it has quietly built an 8.2% stake in Scripps’ Class A non‑voting shares and is actively pushing for a takeover.Reuters+1 The disclosure, made in a regulatory
17 November 2025
···
1 … 2,155 2,156 2,157 2,158 2,159 … 2,716

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop